A patient with major depression disorder, recurrent, severe…

A patient with major depression disorder, recurrent, severe is being started on esketamine, which is administered intranasally by a patented device. The pharmacy company only creates devices with 28 mg in each and each device costs $275. The clinic orders esketamine 84 mg intranasally twice weekly for 4 weeks, then weekly for 4 weeks.For the entire 8 week treatment, the patient will need to buy devices.For the entire 8 week treatment, the patient will pay $.